monocentric Evaluation of incidence of psychosocial comorbidities in patients with atopic dermatitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00016946

Enrollment

100

Registered

2019-03-14

Start date

2019-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L20.8

Interventions

Group 1: patients with atopic dermatitis evaluation of incidence of psychosocial comorbidities (such as anxiety, depression, social network) and the influence of duration, severity, therapy Options o

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: atopic dermatitis diagnosed by a doctor, signed declaration of consent

Exclusion criteria

Exclusion criteria: Age below 18, no atopic dermatitis, no signed declaration of consent

Design outcomes

Primary

Measure	Time frame
Allgemeine Depressionsskala (ADS), Generalized Anxiety Disorder (GAD-7, Lubben social Network Scale (LSNS), Health Survey (SF-8), Dermatological Quality of Life Index, HADS-D - Hospital Anxiety and Depression Scale - Deutsche Version	—

Secondary

Measure	Time frame
self-medication with drugs, utilization of alternative healing methods	—

Countries

Germany

Contacts

Public ContactPaula Kage

Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie Universitätsklinikum Leipzig

paula.kage@uniklinik-leipzig.de03419718364

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026